The a-dystroglycan N-terminus is a broad-spectrum antiviral agent against SARS-CoV-2 and enveloped viruses (2024)
Attributed to:
G2P-UK; A National Virology Consortium to address phenotypic consequences of SARSCoV-2 genomic variation
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.antiviral.2024.105837
Publication URI: http://dx.doi.org/10.1016/j.antiviral.2024.105837
Type: Journal Article/Review
Parent Publication: Antiviral Research